Physician profile
Christopher Audu
NPI 1457715302
$4,316.31
in general payments reported to CMS, 2019-2025
9 companies · $1,393 in 2025
The $1,393 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $73.89 · 2021: $95.68 · 2022: $357 · 2024: $2,397 · 2025: $1,393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,578 · Food and Beverage: $1,213 · Grant: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,577.51 |
| Food and Beverage | $1,212.55 |
| Grant | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,167.35 | 2021-2025 | Indigo System, Penumbra System |
| Medtronic, INC. | $1,191.37 | 2024-2025 | Endurant Iis |
| Silk Road Medical, INC. | $406.12 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Stryker Corporation | $156.62 | 2025 | Artix Mt |
| Bolton Medical INC | $151.75 | 2025 | Treo Abdominal Stent-Graft System |
| Cook Medical LLC | $92.59 | 2024 | Zenith, Zilver Ptx |
| Medtronic Vascular, INC. | $73.89 | 2020 | |
| W. L. Gore & Associates, INC. | $43.47 | 2024 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Bard Peripheral Vascular, INC. | $33.15 | 2024 | Lutonix Drug Coated Balloon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Audu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.